Art

J-GLOBAL ID：201902240609647906   Reference number：19A1171146

A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial

S-1アジュバント療法後の早期再発を伴う進行胃癌患者に対するカペシタビン+シスプラチン(XP)の第II相試験:XParTS-I試験

Author (22)： Nishikawa Kazuhiro (Department of Surgery, Osaka National Hospital, Osaka, Japan) ,  Tsuburaya Akira (Department of Surgery, Tsuboi Cancer Center Hospital, Koriyama, Japan) ,  Yoshikawa Takaki (Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan) ,  Takahashi Masazumi (Department of Surgery, Yokohama Municipal Citizen’s Hospital, Yokohama, Japan) ,  Tanabe Kazuaki (Department of Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan) ,  Yamaguchi Kensei (Division of Gastroenterology, Saitama Cancer Center, Kita-Adachi-Gun, Japan) ,  Yoshino Shigefumi (Oncology Center, Yamaguchi University Hospital, Ube, Japan) ,  Namikawa Tsutomu (Department of Surgery I, Kochi Medical School, Nankoku, Japan) ,  Aoyama Toru (Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan) ,  Rino Yasushi (Department of Surgery, Yokohama City University, Yokohama, Japan) ,  Kawada Junji (Department of Surgery, Osaka General Medical Center, Osaka, Japan) ,  Tsuji Akihito (Department of Clinical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan) ,  Taira Koichi (Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan) ,  Kimura Yutaka (Department of Surgery, Faculty of Medicine, Kindai University, Osakasayama, Japan) ,  Kodera Yasuhiro (Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Hirashima Yoshinori (Department of Medical Oncology and Hematology, Faculty of Medicine, Oita University, Oita, Japan) ,  Yabusaki Hiroshi (Department of Gastroenterological Surgery, Niigata Cancer Center Hospital, Niigata, Japan) ,  Hirabayashi Naoki (Department of Surgery, Hiroshima City Asa Hospital, Hiroshima, Japan) ,  Fujitani Kazumasa (Department of Surgery, Osaka General Medical Center, Osaka, Japan) ,  Miyashita Yumi (Epidemiological and Clinical Research Information Network (ECRIN), Okazaki, Japan) ,  Morita Satoshi (Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan) ,  Sakamoto Junichi (Tokai Central Hospital, Kakamigahara, Japan)
Material： Gastric Cancer (Web)
Volume： 21  Issue： 5  Page： 811-818  Publication year： 2018 
JST Material Number： U0618A  ISSN： 1436-3291  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： phase 2 study ,...
Semi thesaurus term： *cisplatin ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1171146&from=J-GLOBAL&jstjournalNo=U0618A") }}

Author keywords (5)： Advanced gastric cancer ,  Capecitabine plus cisplatin (XP) ,  S-1 adjuvant therapy ,  Early relapse ,  Fluoropyrimidine switching

JST classification (3)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Tumors(=neoplasms)of digestive system  (GH04000D) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (2)： TS-1 ,  Capecitabine

Terms in the title (10)： S-1 ,  アジュバント療法 ,  早期再発 ,  進行胃癌 ,  患者 ,  カペシタビン ,  シスプラチン ,  XP ,  第II相試験 ,  試験